A CASE OF KRAS-MUTATED JMML WITH HIGH METHYLATION PROFILE AND PERPLEXED CLINICAL COURSE.
Main Authors: | Vasiliki Tzotzola, Kondylia Antoniadi, Charikleia Kelaidi, Loizos Petrikkos, Elda Ioannidou, Evgenios Goussetis, Aikaterini Bountali, Kalliopi Manola, Elpidoforos Mantadakis, Kalliopi Stefanaki, Ioulia Peristeri, Charlotte Niemeyer, Sophia Polychronopoulou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | EJC Paediatric Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772610X23000752 |
Similar Items
-
THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (t-MDS) IN CHILDHOOD: THE EXPERIENCE OF THE HELLENIC STUDY GROUP FOR MDS/JMML/SAA, MEMBER OF THE EWOG-MDS/SAA WORKING GROUP
by: Loizos Petrikkos, et al.
Published: (2023-12-01) -
BCR:ABL-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS IN CHILDREN AND ADOLESCENTS: INCREASED DISEASE BURDEN IN PATIENTS WITH JAK2 MUTATION, UNMET DIAGNOSTIC NEEDS AND OPTIMAL TREATMENT OPTIONS
by: Charikleia Kelaidi, et al.
Published: (2023-12-01) -
IMMUNOPHENOTYPE IN SAMD9/9L SYNDROME: CORRELATIONS WITH MORPHOLOGY
by: Charikleia Kelaidi, et al.
Published: (2023-12-01) -
Prognostic Factors for Cardiotoxicity among Children with Cancer: Definition, Causes, and Diagnosis with Omics Technologies
by: Kondylia Antoniadi, et al.
Published: (2023-05-01) -
HOW TO DESIGN THE NEXT CLINICAL TRIAL IN JMML
by: CHARLOTTE NIEMEYER
Published: (2023-12-01)